Pilot Randomized Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer (Depression)
|Columbia University Velocity Grant
|Male and Female Patients
|U.S. Govt. ID:
|Alexandra Mackay: 646-774-8027 / firstname.lastname@example.org
The goal of this research study is to compare evidence-based tele-therapies for patients with non-metastatic breast cancer and comorbid major depression. Participants will be randomly assigned (like by the flip of a coin) to receive twelve weeks of either interpersonal therapy (IPT) or pharmacotherapy with a serotonin reuptake inhibitor, either venlafaxine XR (Effexor) or escitalopram (Lexapro). All sessions will be held virtually via Zoom. Participants will be assessed by independent evaluators and will complete self-report questionnaires throughout the study. There will be a blood sample collected at the beginning and end of the study to measure C-reactive protein, a marker of inflammation elevated in both breast cancer and depression. Participants will be offered $50 compensation as a token of thanks for completing the final evaluation at Week 12.
John Markowitz, MD
|Are you currently depressed?
|Have you been diagnosed with non-metastatic breast cancer in the last 10 years?
|Do you have access to a smart phone, tablet, or computer with a camera and reliable internet connection?
|Are you currently receiving treatment for depression?